Chardan Capital Positive on Kodiak Sciences' (KOD) $225M Baker Bros. Royalty Deal

December 2, 2019 11:44 AM EST Send to a Friend
Chardan Capital Markets analyst Gbola Amusa reiterated a Buy rating and $40.00 price target on Kodiak Sciences Inc. (NASDAQ: KOD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login